⌘K

Login Start Free

Home/Filings/4/0001415889-22-004098

4//SEC Filing

MULLEN JAMES C 4

Accession 0001415889-22-004098

CIK 0001650664other

View on SEC.gov Company Profile

Filed

Apr 17, 8:00 PM ET

Accepted

Apr 18, 4:15 PM ET

Size

5.3 KB

Accession

0001415889-22-004098

Insider Transaction Report

Form 4

Period: 2022-04-14

Editas Medicine, Inc.EDIT

Director

Transactions

Award
Stock Option (right to buy)
2022-04-14+170,989→ 170,989 total
Exercise: $45.69Exp: 2031-03-01→ Common Stock (170,989 underlying)

Footnotes (1)

[F1]Reflects the vesting, upon the satisfaction of the performance criteria, of a portion of a performance-based stock option originally granted on March 2, 2021.

Documents

1 file

4
form4-04182022_040401.xmlPrimary

Issuer

Editas Medicine, Inc.

CIK 0001650664

Entity typeother

IncorporatedMA

Related Parties

1

filerCIK 0001226288

Filing Metadata

Form type: 4
Filed: Apr 17, 8:00 PM ET
Accepted: Apr 18, 4:15 PM ET
Size: 5.3 KB

View on SEC.gov